NERLYNX is being made available in Thailand by an Australian-headquartered company, Specialised Therapeutics, under an exclusive licensing arrangement. The therapy was approved by the TGA in 2019 but is not reimbursed via the PBS.
Specialised Therapeutics brings new hope to women with HER2-positive breast cancer in Thailand
January 22, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech

